Ceryvyn Therapeutics Ltd. - Unsponsored ADR CYVNY

0.02 0.00 0.00% as of 24 Sep
Market cap
$524.8M
P/E
0.0×

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Older periods Dec '23 Jun '24 Dec '24 Jun '25
Net Income

+7 more TTM periods

0.00 0.00 0.00 0.00
Depreciation & Amortization
— 0.00 — 0.00
Non Cash Items (Other)
(185.49) — (239.89) —
Other operating activities
(330.59) (420.27) (351.06) (389.10)
Operating Cash Flow
(330.59) (420.27) (423.55) (461.59)
Capital expenditures
(0.05) (0.07) (0.07) (0.06)
Net Aquisitions
— 0.00 — 0.00
Investing cash flow
(0.05) (0.07) (0.07) (0.06)
Repayment/Issuance of Debt (Net)
(0.09) (0.09) (0.11) (0.11)
Equity Repurchase (Common, Net)
257.05 — 171.26 —
Dividends Paid (Total)
— 0.00 — 0.00
Other financial activities
— 339.00 — —
Financing cash flow
473.04 716.59 584.17 451.65
Exchange Rate Adjustment
(6.38) (3.39) (5.38) (3.42)
Change in Cash
136.02 292.86 155.17 (13.42)
Beginning Cash
296.64 267.64 395.48 523.32
Ending Cash
432.66 560.50 550.65 509.90
Dividends Paid (Common)
0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
— 0.00 — 0.00
Investments Change (Net)
— 0.00 — 0.00
Issuance/Purchase of Shares
219.29 377.85 329.94 281.94

Fold the line items

In millions of $ except per-share values · columns are period end dates